Resources & news
Supporting better breast healthcare through shared knowledge.
BIGOSA is committed to advancing breast healthcare through education, collaboration and the sharing of knowledge. This resource hub brings together clinical guidance, society publications, educational material and organisational updates to support healthcare professionals across Southern Africa.
As BIGOSA continues to grow, this library will expand to become a valuable resource for the multidisciplinary breast healthcare community.
Clinical resources
Access evidence-based resources to support clinical practice and professional development.
The Requirements of a Specialist Breast Centre
Biganzoli L, Cardoso F, Beishon M, et al.
The Breast, Vol 51 (2020), pp. 65–84 · Produced by EUSOMA, endorsed by ECCO and ESMO
Sets out the multidisciplinary team, minimum patient-volume, and quality-control standards a specialist breast centre must meet. This is the European benchmark BIGOSA’s own South African requirements were built against.
Establishing Requirements for Breast Centers in Low- and Middle-Income Countries: A South African Perspective
Nietz S, Edge J, Buccimazza I, et al.
JCO Global Oncology 11:e2500168 (2025) · Endorsed by BIGOSA, SASCRO and CANSA
The first South African–specific requirements for breast centres, built by a 29-expert consensus panel and tailored to local resource constraints. Includes an eight-step implementation pathway and BIGOSA’s own registration process for new centres.
Breast Cancer and Radiation Therapy
Dr Sudeshen Naidoo
Specialist Radiation Oncologist, BIGOSA EXCO Member.
BIGOSA Position Statement · 28 July 2024
Sets out when radiation therapy is indicated after breast-conserving surgery and mastectomy, the timing window after surgery, and the evidence for reduced recurrence and improved survival – five key messages at a glance.
Recommendations for Breast Cancer Screening
Endorsed by BIGOSA
Adapted from BISSA/RSSA Screening Recommendations, Version 1.2 (June 2022)
A two-tier screening pathway by lifetime breast cancer risk – average/mildly increased risk versus high risk (BRCA carriers and other high-risk groups) – with the age to start, age to reassess, and screening frequency for each.